Clinical trial
The Efficacy of Auto-crosslinked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception:a Randomized Controlled Trial
NCT05085067 is registered in ClinicalTrials.gov with Fu Xing Hospital, Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Auto-crosslinked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception:a Randomized Controlled Trial
- Lead sponsor
- Fu Xing Hospital, Capital Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2022
- Completion date
- May 30, 2025
- Enrollment
- 86 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
retained products of conception